May 02, 2012
Vessix Vascular, a pre-revenue stage medical technology company, and product innovation consultancy Karten Design introduce the V2 Renal Denervation System™ — a new device treatment for high blood pressure.
In as little as 30 seconds per artery, the Vessix V2 System performs a one-time minimally invasive catheter-based percutaneous procedure shown to significantly reduce blood pressure.
This new technology has the potential to help the one in three adults in the United States who suffer from hypertension — a condition more common than cancer, diabetes, and coronary artery disease combined. Today, anti-hypertensive drugs are the primary treatment for hypertension. But despite the widespread use of drugs, only about half of hypertensive patients around the world are well controlled, even when multiple medications are taken at optimal dosages. A change is now underway.
The V2 System performs a new procedural treatment called renal denervation, which Dr. Mehmet Oz has called “a profound game changer.” It uses a short blast of radiofrequency (RF) energy to disable the nerves surrounding the arteries leading to the kidneys, treating one of the key physiological contributors to hypertension.
Vessix’s patented V2 Catheter, a balloon catheter with a unique configuration of RF electrodes mounted on its exterior, makes this procedure faster and safer. It delivers precise temperature-controlled RF energy from the V2 RF Generator to both renal arteries in 60 seconds, while the only other competitively marketed Renal Denervation system takes 50-60 minutes. The rapidity of the V2’s treatment promises to reduce patient discomfort as well as exposure to radiation for both the patient and the interventional cardiologist performing the procedure.
Vessix Vascular chose Karten Design, an award-winning product innovation consultancy with a 28-year history of commercializing new medical devices, to give physical form to its technology...This is just as important with medical devices as it is with consumer technology, if not more so because the stakes are so high.”
To ensure the system’s design supports the physician’s natural workflow in the catherization lab, Karten Design worked with Vessix during the early phases of product definition, visiting hospital cath labs and interviewing doctors to determine the system’s ideal usage. Karten Design researchers and designers learned about the human factors surrounding a catheter-based procedure, including visibility, access, and sterility. Resulting design innovations include:
About Vessix Vascular, Inc.
Vessix, founded in 2003, is a privately held pre-revenue stage company developing novel radiofrequency balloon catheter technology. The Company is backed by world-class venture capital investors including NeoMed Management, Edmond de Rothschild, OrbiMed Advisors and Fjord Ventures. For more information on Vessix Vascular, please visit the Company’s website at http://www.vessixvascular.com.
About Karten Design
Karten Design is an award-winning product innovation consultancy that believes in creating positive experiences between people and products. Inspired by consumers’ needs and desires, Karten Design works with leading companies to create differentiated products that build strong brands. The firm has been Connecting Creativity with Commerce™ for more than 28 years with a collaborative approach to innovation that integrates Design Strategy and Research, Industrial Design and Mechanical Engineering.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9466430.htm